We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M Turnover 16.67%
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
-9.79%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$94.8M
AUM Growth
-$17.9M
Cap. Flow
-$784K
Cap. Flow %
-0.83%
Top 10 Hldgs %
44.47%
Holding
86
New
5
Increased
12
Reduced
38
Closed
4
Avg Time Held
5.6 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
BFLY icon
Butterfly Network
BFLY
+$983K
2
ELUT icon
Elutia
ELUT
+$835K
3
SERA icon
Sera Prognostics
SERA
+$764K
4
CXDO icon
Crexendo
CXDO
+$708K
5
CDXS icon
Codexis
CDXS
+$506K

Top Sells

Rank Stock Value
1
DGII icon
Digi International
DGII
+$1.52M
2
AIRG icon
Airgain
AIRG
+$760K
3
TCMD icon
Tactile Systems Technology
TCMD
+$610K
4
NOTV icon
Inotiv
NOTV
+$497K
5
OPRX icon
OptimizeRx
OPRX
+$380K

Sector Composition

Rank Sector Weight
1 Healthcare 61.79%
2 Technology 21.52%
3 Communication Services 7.23%
4 Consumer Staples 4.16%
5 Industrials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LLY icon
1
Eli Lilly
LLY
$1.12T
$8.09M 8.53%
9,795
-115
-1% -$95.7K
2013 Q2
47 quarters
NTRA icon
2
Natera
NTRA
$58.3B
$7.05M 7.43%
49,825
-850
-2% -$137K
2018 Q2
27 quarters
AXGN icon
3
Axogen
AXGN
$2.09B
$4.69M 4.95%
253,534
-7,690
-3% -$139K
2013 Q3
46 quarters
MSFT icon
4
Microsoft
MSFT
$4.01T
$4.65M 4.9%
12,385
-25
-0.2% -$10.2K
2014 Q1
44 quarters
IDXX icon
5
Idexx Laboratories
IDXX
$43.1B
$4.07M 4.3%
9,700
– –
2013 Q3
46 quarters
ABT icon
6
Abbott
ABT
$181B
$2.96M 3.12%
22,330
– –
2014 Q1
44 quarters
ELUT icon
7
Elutia
ELUT
$34.9M
$2.88M 3.03%
1,136,377
+276,300
+32% +$835K
2020 Q4
17 quarters
LMAT icon
8
LeMaitre Vascular
LMAT
$1.9B
$2.72M 2.87%
32,386
-250
-0.8% -$23.3K
2022 Q3
10 quarters
VCYT icon
9
Veracyte
VCYT
$3.57B
$2.57M 2.71%
86,550
-3,650
-4% -$139K
2018 Q1
28 quarters
OOMA icon
10
Ooma
OOMA
$565M
$2.5M 2.64%
191,179
+770
+0.4% +$10.9K
2018 Q2
27 quarters
INUV icon
11
Inuvo
INUV
$7.58M
$2.49M 2.63%
701,532
-6,813
-1% -$31.2K
2018 Q2
27 quarters
AMD icon
12
Advanced Micro Devices
AMD
$918B
$2.14M 2.25%
20,804
– –
2018 Q1
28 quarters
CTLP icon
13
DELISTED
Cantaloupe
CTLP
$1.85M 1.95%
234,600
-1,750
-0.7% -$15.5K
2020 Q4
17 quarters
ATEC icon
14
Alphatec Holdings
ATEC
$1.69B
$1.83M 1.93%
180,517
-1,050
-0.6% -$11.3K
2019 Q3
22 quarters
NEO icon
15
NeoGenomics
NEO
$2.22B
$1.7M 1.8%
179,550
+600
+0.3% +$7.49K
2013 Q2
47 quarters
MDXH icon
16
MDxHealth
MDXH
$57.6M
$1.68M 1.77%
1,181,475
+198,000
+20% +$358K
2021 Q4
13 quarters
MGNI icon
17
Magnite
MGNI
$3.51B
$1.66M 1.75%
145,125
+1,300
+0.9% +$20.7K
2018 Q2
27 quarters
XGN icon
18
Exagen
XGN
$207M
$1.52M 1.6%
422,971
-750
-0.2% -$2.83K
2019 Q3
22 quarters
USIO icon
19
Usio Inc
USIO
$81.4M
$1.45M 1.53%
995,693
– –
2022 Q4
9 quarters
BLZE icon
20
Backblaze
BLZE
$613M
$1.38M 1.45%
285,525
+300
+0.1% +$1.85K
2022 Q3
10 quarters
ABBV icon
21
AbbVie
ABBV
$501B
$1.31M 1.38%
6,230
-78
-1% -$15.2K
2019 Q1
24 quarters
VCEL icon
22
Vericel Corp
VCEL
$2.1B
$1.19M 1.25%
26,600
-1,050
-4% -$56.5K
2014 Q3
42 quarters
GILD icon
23
Gilead Sciences
GILD
$195B
$1.16M 1.22%
10,333
-500
-5% -$51.6K
2020 Q1
20 quarters
TELA icon
24
TELA Bio
TELA
$45.6M
$1.11M 1.17%
910,615
+2,750
+0.3% +$6.76K
2022 Q3
10 quarters
LFVN icon
25
LifeVantage
LFVN
$75.5M
$1.1M 1.16%
75,508
-400
-0.5% -$7.54K
2013 Q2
47 quarters
1
2 3 4

Similar funds

AA
Alpha Advisors Richmond, Virginia $133M AUM 20.23% 1-Year Est. Return
WA
Winter & Associates St. Paul, Minnesota $133M AUM
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
HAP
Harbor Asset Planning Belmont, Massachusetts $133M AUM 24.86% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
CWM
Capstone Wealth Management Billings, Montana $133M AUM
SI
Severin Investments St. Louis, Missouri $133M AUM 45.69% 1-Year Est. Return

Perkins Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Perkins Capital Management held 86 positions worth $94.8M, down 16% from $113M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perkins Capital Management's Q1 2025 filing shows 5 new, 12 increased, 38 reduced and 4 closed positions. Its largest new stake was Butterfly Network: 275,000 shares worth $627K. The largest sale was Digi International, an estimated $1.52M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 58% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q1 2025 buy was Butterfly Network: 275,000 shares worth $627K.
  • Perkins Capital Management added most to Elutia in Q1 2025, an estimated $835K increase.
  • Perkins Capital Management's biggest Q1 2025 reduction was Digi International, cutting an estimated $1.52M.
  • Perkins Capital Management fully exited Inotiv in Q1 2025, selling an estimated $497K.
  • Perkins Capital Management's ten largest holdings make up 44% of its $94.8M portfolio in Q1 2025.
  • Perkins Capital Management opened 5 new positions and closed 4 in Q1 2025.
  • Perkins Capital Management's portfolio value fell 16% quarter-over-quarter to $94.8M.

Based on Perkins Capital Management's 13F filing for Q1 2025, filed 7 May 2025.